Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Neural metabolite changes in corpus striatum after rat multipotent mesenchymal stem cells transplanted in hemiparkinsonian rats by magnetic resonance spectroscopy.

Fu W, Zheng Z, Zhuang W, Chen D, Wang X, Sun X, Wang X.

Int J Neurosci. 2013 Dec;123(12):883-91. doi: 10.3109/00207454.2013.814132. Epub 2013 Aug 1.

PMID:
23768098
2.

Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: focusing on neuroprotective effects of stromal cell-derived factor-1alpha.

Wang F, Yasuhara T, Shingo T, Kameda M, Tajiri N, Yuan WJ, Kondo A, Kadota T, Baba T, Tayra JT, Kikuchi Y, Miyoshi Y, Date I.

BMC Neurosci. 2010 Apr 26;11:52. doi: 10.1186/1471-2202-11-52.

3.

[Biochemical changes in striatum of Parkinson's disease rat model observed by modified proton magnetic resonance spectroscopy].

Zheng Z, Fu W, Wang J, Sun X, Zhuang W, Lu E, Yang L, Lu C.

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2010 Jun;27(3):524-8. Chinese.

PMID:
20649011
4.

Parkinson's disease: in vivo metabolic changes in the frontal and parietal cortices in 6-OHDA treated rats during different periods.

Hou Z, Zhang Z, Meng H, Lin X, Sun B, Lei H, Fang K, Fang F, Liu M, Liu S.

Int J Neurosci. 2014 Feb;124(2):125-32. doi: 10.3109/00207454.2013.825616. Epub 2013 Aug 15.

PMID:
23931110
5.

Effect of human umbilical cord blood mesenchymal stem cell transplantation on neuronal metabolites in ischemic rabbits.

Guan YM, Zhu Y, Liu XC, Huang HL, Wang ZW, Liu B, Zhu YZ, Wang QS.

BMC Neurosci. 2014 Mar 17;15:41. doi: 10.1186/1471-2202-15-41.

6.

Intrastriatal transplantation of mouse bone marrow-derived stem cells improves motor behavior in a mouse model of Parkinson's disease.

Offen D, Barhum Y, Levy YS, Burshtein A, Panet H, Cherlow T, Melamed E.

J Neural Transm Suppl. 2007;(72):133-43.

PMID:
17982886
7.

Reversal of dopaminergic degeneration in a parkinsonian rat following micrografting of human bone marrow-derived neural progenitors.

Glavaski-Joksimovic A, Virag T, Chang QA, West NC, Mangatu TA, McGrogan MP, Dugich-Djordjevic M, Bohn MC.

Cell Transplant. 2009;18(7):801-14. doi: 10.3727/096368909X470801. Epub 2009 Sep 28.

PMID:
19796495
8.

Environmental cue-dependent dopaminergic neuronal differentiation and functional effect of grafted neuroepithelial stem cells in parkinsonian brain.

Mine Y, Hayashi T, Yamada M, Okano H, Kawase T.

Neurosurgery. 2009 Oct;65(4):741-53; discussion 753. doi: 10.1227/01.NEU.0000351281.45986.76. Erratum in: Neurosurgery. 2009 Dec;65(6):1062.

PMID:
19834380
9.

Therapeutic effect of human amniotic epithelial cell transplantation into the lateral ventricle of hemiparkinsonian rats.

Yang XX, Xue SR, Dong WL, Kong Y.

Chin Med J (Engl). 2009 Oct 20;122(20):2449-54.

PMID:
20079158
10.
11.

Intravenous mesenchymal stem cell administration exhibits therapeutic effects against 6-hydroxydopamine-induced dopaminergic neurodegeneration and glial activation in rats.

Suzuki S, Kawamata J, Iwahara N, Matsumura A, Hisahara S, Matsushita T, Sasaki M, Honmou O, Shimohama S.

Neurosci Lett. 2015 Jan 1;584:276-81. doi: 10.1016/j.neulet.2014.10.039. Epub 2014 Nov 1. Erratum in: Neurosci Lett. 2015 Feb 5;587:5. Iwahara, Naoyuki [corrected to Iwahara, Naotoshi].

PMID:
25449872
12.

bFGF promotes the differentiation and effectiveness of human bone marrow mesenchymal stem cells in a rotenone model for Parkinson's disease.

Xiong N, Yang H, Liu L, Xiong J, Zhang Z, Zhang X, Jia M, Huang J, Zhang Z, Mohamed AA, Lin Z, Wang T.

Environ Toxicol Pharmacol. 2013 Sep;36(2):411-22. doi: 10.1016/j.etap.2013.05.005. Epub 2013 May 22.

PMID:
23770451
13.

Morphological and metabolic changes in the nigro-striatal pathway of synthetic proteasome inhibitor (PSI)-treated rats: a MRI and MRS study.

Delli Pizzi S, Rossi C, Di Matteo V, Esposito E, Guarnieri S, Mariggiò MA, Franciotti R, Caulo M, Thomas A, Onofrj M, Tartaro A, Bonanni L.

PLoS One. 2013;8(2):e56501. doi: 10.1371/journal.pone.0056501. Epub 2013 Feb 19.

14.

Neural stem/progenitor cells survive and differentiate better in PD rats than in normal rats.

Sun ZH, Lai YL, Zeng WW, Zhao D, Zuo HC, Xie ZP.

Acta Neurochir Suppl. 2003;87:169-74.

PMID:
14518547
15.

Regenerative therapy in experimental parkinsonism: mixed population of differentiated mouse embryonic stem cells, rather than magnetically sorted and enriched dopaminergic cells provide neuroprotection.

Tripathy D, Verma P, Nthenge-Ngumbau DN, Banerjee M, Mohanakumar KP.

CNS Neurosci Ther. 2014 Aug;20(8):717-27. doi: 10.1111/cns.12295. Epub 2014 Jun 21.

PMID:
24954161
16.

Increased progenitor cell proliferation and astrogenesis in the partial progressive 6-hydroxydopamine model of Parkinson's disease.

Aponso PM, Faull RL, Connor B.

Neuroscience. 2008 Feb 19;151(4):1142-53. doi: 10.1016/j.neuroscience.2007.11.036. Epub 2007 Dec 4.

PMID:
18201835
17.
18.

Neuronal firing activity and gene expression changes in the subthalamic nucleus after transplantation of dopamine neurons in hemiparkinsonian rats.

Rumpel R, Alam M, Klein A, Özer M, Wesemann M, Jin X, Krauss JK, Schwabe K, Ratzka A, Grothe C.

Neurobiol Dis. 2013 Nov;59:230-43. doi: 10.1016/j.nbd.2013.07.016. Epub 2013 Aug 11.

PMID:
23938762
19.

Long-term efficacy and safety of human umbilical cord mesenchymal stromal cells in rotenone-induced hemiparkinsonian rats.

Xiong N, Cao X, Zhang Z, Huang J, Chen C, Zhang Z, Jia M, Xiong J, Liang Z, Sun S, Lin Z, Wang T.

Biol Blood Marrow Transplant. 2010 Nov;16(11):1519-29. doi: 10.1016/j.bbmt.2010.06.004. Epub 2010 Jun 10.

20.

Intranigral transplantation of solid tissue ventral mesencephalon or striatal grafts induces behavioral recovery in 6-OHDA-lesioned rats.

Palmer MR, Granholm AC, van Horne CG, Giardina KE, Freund RK, Moorhead JW, Gerhardt GA.

Brain Res. 2001 Jan 26;890(1):86-99.

PMID:
11164771
Items per page

Supplemental Content

Write to the Help Desk